Profound Medical (TSE:PRN) Issues Quarterly Earnings Results

Profound Medical (TSE:PRN) released its quarterly earnings data on Thursday. The company reported C$0.26 earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$7.42 million for the quarter. Profound Medical had a negative net margin of 248.45% and a negative return on equity of 85.73%.

Profound Medical Stock Performance

TSE PRN traded up C$0.68 during trading hours on Friday, hitting C$10.43. The company had a trading volume of 11,310 shares, compared to its average volume of 18,365. The company has a quick ratio of 14.98, a current ratio of 12.52 and a debt-to-equity ratio of 7.09. The firm has a market cap of C$378.55 million, a P/E ratio of -7.40 and a beta of 1.00. Profound Medical has a fifty-two week low of C$5.23 and a fifty-two week high of C$12.40. The business has a fifty day simple moving average of C$8.78 and a 200-day simple moving average of C$9.29.

Insider Activity

In other news, Director Dr. Arun Menawat purchased 20,000 shares of the stock in a transaction dated Friday, March 20th. The stock was acquired at an average price of C$6.96 per share, for a total transaction of C$139,200.00. Following the completion of the transaction, the director owned 658,660 shares of the company’s stock, valued at approximately C$4,584,273.60. The trade was a 3.13% increase in their ownership of the stock. Company insiders own 8.62% of the company’s stock.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.